CTOR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Citius Oncology Inc

Watchlist Manager

Watchlist

Price: 0.768 USD 2.95% Market Closed

Market Cap: $71.4m

C	Citius Oncology Inc NASDAQ:CTOR	US
S	Shalibhadra Finance Ltd BSE:511754	IN
	Wesco International Inc NYSE:WCC	US
R	Rockpool Acquisitions PLC LSE:ROC	UK
I	ITV PLC F:IJ7	UK
S	SA Corporate Real Estate Ltd JSE:SAC	ZA
	Fagerhult Group AB STO:FAG	SE
	Lion Corp OTC:LIOPY	JP
A	Advanced Micro Devices Inc MIL:1AMD	US
N	NetApp Inc F:NTA	US
	Casta Diva Group SpA MIL:CDG	IT
	Sony Group Corp TSE:6758	JP
A	Avient Corp XMUN:PY9	US
	Strategic Education Inc NASDAQ:STRA	US

Profitability Summary

Citius Oncology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

79%

Negative Operating Margin

-641%

Negative 3Y Average Operating Margin

-661%

Negative Net Margin

-648%

Negative 3Y Average Net Margin

-668%

Negative Free Cash Flow Margin

-273%

Negative 3Y Average Free Cash Flow Margin

-299%

Negative ROE

-127%

Negative 3Y Average ROE

-95%

Negative ROIC

-53%

Negative 3Y Average ROIC

-45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.